Company Filing History:
Years Active: 2001-2009
Title: Innovative Contributions of Hong-Bing Shu in Apoptosis Research
Introduction
Hong-Bing Shu, an accomplished inventor based in South San Francisco, CA, has made significant strides in the field of apoptosis research. He holds two patents that delve into the mechanisms of cell death regulation, contributing to both scientific understanding and potential therapeutic applications. His work is particularly focused on apoptosis-regulating proteins known as Casper proteins.
Latest Patents
Shu's latest patents revolve around the invention of methods and compositions related to apoptosis regulating proteins, specifically the Casper proteins. These innovations include techniques for producing these proteins recombinantly from transformed host cells or purifying them from human cells. Moreover, his patents encompass the formulation of specific hybridization probes and primers capable of hybridizing with the Casper gene, as well as Casper-specific binding agents such as antibodies. The methodologies outlined have applications in diagnosis, therapy, and the biopharmaceutical industry, showcasing the potential for impactful medical advancements.
Career Highlights
Throughout his career, Hong-Bing Shu has worked with notable companies, including Tularik Limited and Amgen Inc., where he has contributed his expertise to various innovative projects. His dedication to research and development has positioned him as a respected figure in biomedicine, particularly in the study of apoptosis.
Collaborations
During his professional journey, Hong-Bing Shu has collaborated with several prominent scientists, including David V. Goeddel. These partnerships have not only enriched his research but have also fostered advancements in the understanding of cellular mechanisms related to apoptosis.
Conclusion
In conclusion, Hong-Bing Shu's innovative contributions to the field of apoptosis research through his patents on Casper proteins reflect his commitment to advancing biopharmaceutical science. His work holds promise for the development of new diagnostic and therapeutic tools, marking him as a significant contributor to modern medical research.